Notifying partners of HIV-infected people and referring them for testing and treatment is an effective method for identifying individuals with undiagnosed human immunodeficiency virus (HIV) and offering them a range of medical and psychosocial services. Despite this evidence, HIV partner services are underused, and many localities struggle to incrementally improve their partner services. In this article, Udeagu et al. describe a useful approach to increase HIV partner services' yield by targeting hospitals in neighborhoods with high rates of delayed HIV diagnoses. When resources are limited, such targeting of services using surveillance data improves cost-effectiveness and increases program impact.
Nationwide, approximately 21% of individuals infected with human immunodeficiency virus (HIV) are unaware of their infection. 1 HIV partner services (PS), a process of identifying, notifying, and testing HIV-exposed sex and needle-sharing partners, promote early identification of undiagnosed HIV infections-a core objective of all HIV prevention programs. 2 Studies have shown that more patients can be reached for PS, and outcomes can improve, when public health workers are integral in the PS process. [3] [4] [5] However, HIV clinicians and patients have long underutilized the PS system at the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) (Figure 1 ). NYC outcomes for PS lag when compared with other counties in New York State (NYS). 6 Furthermore, a 2004 DOHMH analysis found that disease intervention specialists (DISs) at DOHMH sexually transmitted disease (STD) control clinics elicited four times more partners and were more successful than non-DOHMH providers in notifying and testing partners. 4 Therefore, to increase PS for patients diagnosed by non-DOHMH providers, DOHMH formed the HIV Field Services Unit (FSU) in July 2006 to work collaboratively with providers to expand PS access in NYC neighborhoods hardest hit by the HIV epidemic. 7 Initially, the FSU partnered with eight hospitals serving neighborhoods with high rates of late HIV diagnosis, high HIV prevalence, and mortality. We report outcomes of the first two full years of implementation and lessons learned.
METHODS

Development of DIS field site placements
To introduce the new program, DOHMH program management staff and the DISs designated for each site held in-person meetings with targeted hospitals' HIV care and administrative staff. At the meetings, we reviewed lagging NYC PS outcomes compared with the rest of NYS and the higher yield of PS performed by DOHMH staff at STD clinics compared with the PS outcomes performed by community providers. We also reviewed the NYS laws and regulations pertaining to HIV PS and emphasized the collaborative roles and responsibilities of DOHMH and community providers. A general operational protocol for collaboration was developed and specific steps were tailored to reflect variations in hospital settings. Additional details about this process have been described elsewhere. 8
DIS placement in HIV clinics
Eight experienced DISs were assigned on full-time or on-call bases at voluntarily participating hospitals to provide on-site PS assistance to providers and HIVinfected patients. An additional three field-based DISs performed PS at patients' homes and at prearranged field sites in the community throughout all five NYC boroughs.
PS protocol
Provider referrals, HIV surveillance reports, and partner notifications were used to identify patients needing PS. The NYC HIV/AIDS reporting system (HARS), a population-based surveillance registry of all New Yorkers diagnosed with acquired immuno deficiency syndrome (AIDS) since 1981 and HIV since 2000, was used to prioritize and plan PS. Patients chose a partner notification option: patient-delivered, provider-delivered, or DIS-assisted. Notification of named partners not in HARS was prioritized above already reported partners ( Figure 2 ). DISs or providers screened for domestic violence risk associated with planned notifications; partner notifications proceeded if risk seemed low. We requested that partners authorize access to their HIVnegative test results, which are not reportable in NYS.
In February 2008, DOHMH implemented fieldtesting using the OraSure ® HIV-1 Oral Specimen Collection Device (Orasure Technologies Inc., Bethlehem, Pennsylvania) following partner notification to remove barriers to testing and negative test documentation. PS outcomes were entered into DOHMH's partner notification database. During the partner elicitation interview, DISs assessed patients' understanding of the follow-up care plan made by providers. If DISs identified a lack of understanding on the part of the patient, or reluctance to adhere to the follow-up plan, they attempted to address potential barriers by facilitating appointment scheduling; providing transportation to appointments; and offering a patient brochure explaining HIV transmission, pathogenesis, management, and PS. Exposed partners testing HIV-positive following notification and testing were also linked to medical care.
PS outcomes
At the participating sites pre-intervention, and at nonparticipating sites post-intervention, provider reports of PS outcomes (partner elicited, notified, and tested) were accepted by DOHMH as the final outcome. Providers could report patient-delivered partner notification to DOHMH without having verified the notification by speaking with the named partner. At the participating sites during the post-intervention period, DISs and HIV diagnoses reported each year. PS data for 2005 were obtained from the provider report form (PRF) database, which consists of names of known sex and needle-sharing partners of HIV-infected people (living or deceased) and any PS outcomes performed by the providers or their patients or provider request for DISassisted notification through the health department's longstanding contact notification assistance program. PS data for 2008 for participating providers were extracted from the FSU partner and PRF databases. The partner names in both databases were matched and duplicate reports were identified and merged into one record. PS data for nonparticipating sites in 2005 and 2008 were extracted from the PRF database. We restricted our comparison to newly diagnosed patients because this group's PS need is universal. We used Chisquare tests to compare differences between groups and Fisher's exact test for expected cell values ,5. Statistical significance was set at p#0.05.
RESULTS
Demographics of HIV-positive patients
Of 3,809 patients diagnosed in NYC in 2008, 9 602 (15%) and 635 (16%) were from participating and selected nonparticipating sites, respectively. Significantly (p#0.0001) more patients at participating sites than at nonparticipating sites were black (63% vs. 38%) or reported heterosexual transmission risk (38% vs. 16%). Nonparticipating site patients were more likely than participating site patients to be white (22% vs. 3%), aged 30-39 years (30% vs. 22%), and men who have sex with men (MSM) (56% vs. 24%). The demographic composition of patients at participating and nonparticipating sites did not change significantly 
Comparison of PS outcomes preand post-intervention
As shown in Figure 3 , at participating sites, we observed significant improvements (p#0.0001) in the partnerindex ratio (partners elicited/patients interviewed) Cases that had both PRF and FSU forms were counted as one record, and all partners received on either form were included in the analysis.
d Unless otherwise indicated, proportions were calculated using the number inside the box as the numerator, and the number in the nearest "upstream" box as the denominator. demonstrated significant differences between participating and nonparticipating sites in the post-intervention period. In participating sites, 75% of newly diagnosed patients had a PRF submitted (indicating submission of partner elicitation information from the clinical provider) compared with 44% at nonparticipating sites (p50.0001). Comparison of PRFs from nonparticipating providers to PRFs and FSU reports from participating sites indicated that more partners at participating sites were elicited (474 vs. 13; p50.0001) and notified (194 vs. 1; p50.0001). The number of partners tested could not be compared due to incomplete HIV testing information on partners notified by non-DOHMH providers (data not shown).
DISCUSSION
In 2006, DOHMH expanded HIV PS access through a unique public-private collaboration that markedly improved outcomes at participating sites. The largest expansion of PS access was to black and Hispanic people-two groups disproportionately affected by the HIV epidemic in NYC. 9 Participating providers and clients expressed satisfaction with the collaboration. 8 Key factors in the initiative's success were stationing DISs at HIV clinical sites, integrating DISs into clinical teams, delivering PS and testing at locations chosen by clients, and using surveillance data to plan and prioritize PS. Compared with nonparticipating sites during the same time period, participating sites experienced a substantial improvement in PS outcomes after the introduction of FSU, despite serving a smaller proportion of MSM clients, whose participation in PS has been observed to result in PS outcomes that are greater than or equal to the magnitude of non-MSM PS clients. 10 We observed an HIV seropositivity rate among tested partners (13%) that was lower than previously published rates by PS programs. 11, 12 One potential reason for this difference is that STD program DISs typically lack access to HIV surveillance data to verify clients' self-reported HIV serostatus, 13, 14 resulting in the inclusion of people previously diagnosed with HIV among those reported newly diagnosed through PS. A crucial component of HIV PS is accurate documentation of index and partner characteristics and notification outcomes. Our practice of verifying notifications not performed by health department staff with the exposed partner or provider was very successful. Among our cohort, 88% of patient-delivered notifications were verified, although the fact that clients knew we would be confirming notification with their partner may have prompted them to be more vigilant in their own notification efforts than they might otherwise have been.
We used the opportunity to collaborate with participating sites as a means to improve providers' awareness of their legal obligation in NYS to report HIV-diagnosed patients and their named partners to the health department using the PRF. We distributed our own brochures for providers, which include instructions on reporting cases and partners at initial diagnosis. [15] [16] [17] We also reminded providers of an often overlooked portion of the PRF designed to accommodate reporting of additional, previously unreported partners who might be elicited at follow-up visits after diagnosis and the initial PRF submission. Our encouragement of the use of this form was part of an overall message that HIV-infected patients' need for PS endures for years following diagnosis, and clinic visits are opportunities to address this ongoing need. Providing HIV PS is a complex task that requires time, expertise, and resources to achieve; this initiative provides a consistent and effective alternative to accomplish what is otherwise a time-consuming and difficult process for most NYC providers.
Aside from improving case surveillance, there are other program benefits not captured by the outcome measures reported in this article. We believe that counseling HIV-negative partners after their HIV exposure had a far greater positive impact on clients' HIV risk behaviors than it would have were it delivered under routine HIV testing circumstances. We also used our front-line experience to develop tailored educational materials about PS and HIV prevention for NYC providers and patients, likely further enhancing the impact of our prevention counseling. [15] [16] [17] [18] [19] Furthermore, the FSU's linkage-to-care efforts likely reduced HIV transmission by influencing patients' antiretroviral medication initiation and adherence, leading to lower HIV viral-load levels and transmission risk. 20, 21 Limitations Our findings were subject to several limitations. First, participating facilities served mostly black or Hispanic HIV-positive index cases and, thus, our findings may not be generalizable to other facilities. We may have underestimated the number of notified HIV-exposed partners who were tested for HIV because of the barriers to documenting HIV-negative test results. Because such results are not reportable in NYS, DISs must have Local Acts  113 Public Health Reports / January-February 2012 / Volume 127 partners complete and sign a release of HIV-related information form to verify HIV-negative test results with clinical providers. Many partners refuse to sign this form at notification, and providers may not always report partners' test results to us. We also may have underreported the number of HIV-exposed partners newly diagnosed with HIV infection following partner notification by HIV index patients or community providers. Providers only submit PRFs on 44% of all newly diagnosed HIV patients at nonparticipating facilities; known partners may not have been reported on the forms submitted as required by law, thereby contributing to an undercounting of HIV case findings from provider-or patient-delivered partner notifications.
CONCLUSION
This program's implementation demonstrates that DISs can be integrated into HIV clinical settings to achieve large-scale improvements in community-wide PS outcomes. The favorable response to this program by providers and clients has led to the expansion to 35 facilities in NYC from 2009 through 2011. Preliminary 2009 program data show more improvements in PS outcomes, despite doubling the number of participating sites with no increases in personnel, illustrating efficiency gains achieved as the program matures.
